Andrew Huberman· PhD
GH enhancing: Tesamorelin, CJC, etc
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
GH enhancing: Tesamorelin, CJC, etc
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Tesamorelin is a GHRH, which I kind of loop into the category of GHRPs, so growth hormone-releasing peptides. So it's only a couple amino acids different from endogenously-produced growth hormone-releasing hormone.
Tesamorelin is one of them, sermorelin is another one, and CJC is another common one. I believe those are all in the class of GHRH-like peptides